Ads by Google
Alzheimer's Disease Research is seeking patients for the third phase of a preliminary study for a promising new drug that fights the ravages of Alzheimer's.
An automated system for measuring brain tissue with magnetic resonance imaging can help physicians more accurately diagnose Alzheimer's disease at an earlier stage
Elan Corporation, plc (NYSE: ELN) and Wyeth (NYSE: WYE) today announced encouraging preliminary findings from a Phase 2 study of bapineuzumab (AAB-001) in patients with mild to moderate Alzheimer's disease. In the 18-month trial, bapineuzumab appeared to have clinical activity in treating Alzheimer's disease.
Different types of non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, naproxen, and aspirin, appear to be equally effective in lowering the risk of Alzheimer's disease.
MedPredict has published a new report designed to provide critical strategic insight for pharma and biotech companies with a stake in the market for diagnostics and treatments in Alzheimer's disease area.
Ibuprofen (Advil, Motrin) adds no benefit for Alzheimer's disease prevention compared to other drugs.
Researchers have shown, in unprecedented detail, how a small molecule is able to selectively take apart abnormally folded protein fibers connected to Alzheimer's disease and prion diseases.
The nation's leading organization of assisted living providers urged the Senate Special Committee on Aging to look to assisted living providers for the model of care for victims of Alzheimer's disease.
The anti-inflammatory drugs naproxen and celecoxib do not appear to improve cognitive function in older adults with a family history of Alzheimer's disease, and naproxen may have a slightly detrimental effect.
International review of end-stage dementia patients covers research from 9 countries.